Author

I. Loveless

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 3 Approach:experimental assay· 3 Organism:human· 3 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1

Frequent Co-Authors

A. Hans· 1 shared A. Miller· 1 shared A. Steep· 1 shared C. G. Rogers· 1 shared C. Yin· 1 shared D. A. Chitale· 1 shared D. Ozog· 1 shared D. Rempinski· 1 shared

Activity by Year

2019-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 13 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Hans

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

ROR2 regulates cellular plasticity in pancreatic neoplasia and adenocarcinoma

S. Benitz, A. Steep, M. Nasser, J. Preall, U. M. Mahajan, H. McQuithey, I. Loveless, E. T. Davis, H.-J. Wen, D. W. Long, T. Metzler, S. Zwernik, M. Louw, D. Rempinski, D. Salas-Escabillas, , H. C. Crawford

This study identifies ROR2 as a regulator of cellular plasticity in pancreatic neoplasia, showing it promotes an aggressive PDAC phenotype and resistance to KRAS inhibitors.

bioRxiv · Dec 13, 2023Cancer Biology

Mass cytometry identifies dysregulation of circulating and cutaneous immune cells in patients with hidradenitis suppurativa

P. Dimitrion, I. Hamzavi, C. Yin, I. Loveless, J. Toor, K. Subedi, N. Khalasawi, A. Miller, R. Huggins, I. Adrianto, J. Veenstra, G. Vellaichamy, A. Hans, S. Daveluy, M. Athar, , Q.-S. Mi

This study identifies immune cell dysregulation in hidradenitis suppurativa using mass cytometry and RNA-seq, finding increased CD38 expression in monocytes and suggesting CD38 as a therapeutic target.

bioRxiv · Jan 27, 2023 · PreprintImmunology

Clonal evaluation of prostate cancer molecular heterogeneity in biopsy samples by dual immunohistochemistry and dual RNA in situ hybridization

N. Palanisamy, P. D. Arachchige, S. Carskadon, J. Li, I. Loveless, M. Alhamar, J. O. Peabody, H. Stricker, D. A. Chitale, C. G. Rogers, M. Menon, T. A. Bismar, N. S. Gupta, S. R. Williamson

The paper evaluates molecular heterogeneity in prostate cancer biopsy samples using dual immunohistochemistry and RNA in situ hybridization, finding clonal differences and higher heterogeneity in African American patients.

bioRxiv · Oct 25, 2019Cancer Biology